Seagen (Canada)

Seagen (Canada)

Seagen Inc. is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Seagen (Canada), Canada, covering academic research published from 2002 to 2024. Read More.


Open Access Percentage

68%


Total
Publications

87


Total Open
Publications

59


Total
Citations

6.7K


Open Access
Percentage

68%


Total
Publications

87


Total Open
Publications

59


Total
Citations

6.7K

Wikipedia

Website

download

Breakdown

30% 22% 14% 34%

Publisher Open

30%

Both

22%

Other Platform Open

14%

Closed

34%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

01234567891011Total Publications
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

37%OA Journal

OA Journal 37%

16

Hybrid 21%

9

No Guarantees 42%

18

Other Platform Open

Domain 77%

23

Institution 23%

7

Other Internet 23%

7

Preprint 7%

2

Public 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
23
DOI
Other Internet
7
Harvard University
Institution
2
Harris County Public Library
Institution
2
Washington University in St. Louis
Institution
1
University of Southern Denmark
Institution
1
University of Michigan–Ann Arbor
Institution
1
universiteitleiden.nl OAI-PMH Repository
Institution
1
Royal Netherlands Academy of Arts and Sciences
Institution
1
Research Square
Preprint
1
1 / 2

Data updated 18 August 2025

Share

Share

Share